Haberkamp M

European Medicines Agency's Central Nervous System Working Party (CNSWP), 1083 HS Amsterdam, Netherlands.

2 papers

ArticlePsychedelics

Applying the EU Regulatory Framework to Determine the Benefit-Risk Profile of Psychedelics.

Browne K, Bałkowiec-Iskra E, Elferink A +10

ArticlePsilocybin

Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.

E-Wen McCulloch D, Liechti ME, Kuypers KP +9